European Archives - Page 818 of 1369 - European Medical Journal

Neph 9.1 Content Image

Idefirix® (Imlifidase): A Paradigm Shift in Transplanting the Untransplantable?

Imlifidase was granted a conditional marketing authorisation by the European Commission in August 2020 for “desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor.”36 This milestone launched a new era in kidney transplantation for selected patients who would previously have remained untreated.

Innovations in Haemodialysis

THE ‘Innovations in Haemodialysis’ session of this year’s European Renal Association –European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress 2021 focused on discussing important inclusions to the design and development of new haemodialysis (HD) therapies.

Trace Elements and Chronic Kidney Disease: A Cross-Sectional Study from Jamaica

Trace elements are ubiquitous entities and a fair number of non-essential xenobiotics gain entry into the body via a multitude of ways, including through groundwater (arsenic, strontium, silicon), inhalation of silica dust (silicon), gasoline (lead), cigarette smoke, and soil (cadmium) and food contamination (arsenic, mercury).

FUTURE SCENARIOS FOR RENAL DISEASE ASSOCIATED WITH CLIMATE CHANGE

Future Scenarios for Renal Disease Associated with Climate Change

One of the highlights of this year’s European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) congress, was the session on future scenarios for renal disease.

INTERVIEW: ROBERT JOHN UNWIN

Interview with Robert John Unwin | Professor Emeritus of Nephrology, former Professor of Nephrology and Physiology, University College London, UK; Scientific Advisory Board member of ERA-EDTA

Spontaneous Renal Artery Dissection: Is It Really So Rare?

Spontaneous renal artery dissection (SRAD) is a rare and often unrecognised clinical entity, which accounts for 1–2% of all arterial dissections. It can be the result of several underlying diseases, such as atherosclerosis, malignant hypertension, fibromuscular dysplasia, and connective tissue disorders.

The Non-coding MicroRNA-223 is a Promising Biomarker of Chronic Kidney Disease

Renal diseases are consecutive to a deregulation of gene expression regulated by non-coding RNAs. These non-coding RNAs were discovered at…

Senescence-Like Changes in B-Cell Phenotype in Patients with Haemodialysis

The purpose of this study was to evaluate the effects of haemodialysis (HD) on B-cell subsets, in terms of untimely expression of immunosenescent phenotype.

INTERVIEW: ROBERT JOHN UNWIN

INTERVIEW: PETER J. BLANKESTIJN

Interview with Peter J.Blankestijn | Department of Nephrology and Hypertension, University Medical Centre Utrecht, Netherlands, 2021 Scientific Committee member and former Council member of European Renal Association – European Dialysis and Transplant Association (ERA-EDTA).

The Role of Dexmedetomidine for the Prevention of Acute Kidney Injury in Critical Care

Acute kidney injury (AKI) occurs in up to 50% of patients admitted to the intensive care unit and is associated with increased mortality…